Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

News
COVID-19 in children with cancer: Severe disease and disrupted treatment
08/27/2021
Scientists from St. Jude Children's Research Hospital and the International Society of Paediatric Oncology report results from the Global Registry of COVID-19 and Childhood Cancer.
Scientists from St. Jude Children's Research Hospital and the International Society of Paediatric Oncology report results from the Global Registry of COVID-19 and Childhood Cancer.
Scientists from St. Jude...
08/27/2021
IO Learning
News
GT Medical Technologies Presents Clinical Data on GammaTile® Therapy for Brain Tumors at the 2021 American Association of Neurological Surgeons Scientific Virtual Meeting
08/24/2021
New Data Details How Surgically Targeted Radiation Therapy (STaRT) Provides One-and-Done Radiation Treatment at the Time of Brain Tumor Removal
New Data Details How Surgically Targeted Radiation Therapy (STaRT) Provides One-and-Done Radiation Treatment at the Time of Brain Tumor Removal
New Data Details How Surgically...
08/24/2021
IO Learning

Advertisement

News
Innovative Embolic Device for Treating Tumors Highlighted in “BEST of GEST” Session at the Global Embolization Oncology Symposium Technologies (“GEST”) Conference
08/23/2021
Fluidx Medical’s GPX™ Embolic Device Use for Tumor Treatments Chosen for “BEST of GEST” Embolization Program at the Annual GEST Meeting Fluidx Medical Technology’s GPX Embolic Device was selected for a Global Embolization Oncology...
Fluidx Medical’s GPX™ Embolic Device Use for Tumor Treatments Chosen for “BEST of GEST” Embolization Program at the Annual GEST Meeting Fluidx Medical Technology’s GPX Embolic Device was selected for a Global Embolization Oncology...
Fluidx Medical’s GPX™ Embolic...
08/23/2021
IO Learning
News
Imaging Endpoints Continues Global Expansion
08/10/2021
Leading Oncology iCRO establishes European Office in Basel, Switzerland
Leading Oncology iCRO establishes European Office in Basel, Switzerland
Leading Oncology iCRO...
08/10/2021
IO Learning
News
SIR Publishes New Position Statement and Quality Improvement Document on Percutaneous Lung Ablation
08/02/2021
The Society of Interventional Radiology (SIR) issued a new position statement on percutaneous lung ablation.
The Society of Interventional Radiology (SIR) issued a new position statement on percutaneous lung ablation.
The Society of Interventional...
08/02/2021
IO Learning

Advertisement

News
GenesisCare Extends U.S. Brachytherapy Service With 27 Elekta Flexitron Treatment Devices
07/23/2021
ATLANTA, July 23, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) announced today that GenesisCare, a leading global provider of integrated cancer care, has ordered 27 Flexitron® brachytherapy afterloader systems, including...
ATLANTA, July 23, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) announced today that GenesisCare, a leading global provider of integrated cancer care, has ordered 27 Flexitron® brachytherapy afterloader systems, including...
ATLANTA, July 23,...
07/23/2021
IO Learning
News
Obsidio, Inc. Awarded Prestigious Fast Track Small Business Innovation Research Grant by National Heart, Lung, and Blood Institute
07/22/2021
The grant will provide up to $2.1 million to support the development of gel embolic material (GEM) for transcatheter embolization
The grant will provide up to $2.1 million to support the development of gel embolic material (GEM) for transcatheter embolization
The grant will provide up to...
07/22/2021
IO Learning
News
HistoSonics Announces Milestone As American Medical Association Issues Unique Category III CPT® Code For Histotripsy Of Liver
07/12/2021
MINNEAPOLIS, July 12, 2021 /PRNewswire/ -- HistoSonics, (www.histosonics.com), the developer and manufacturer of a non-invasive platform and novel sonic beam therapy called histotripsy, is pleased to announce that the...
MINNEAPOLIS, July 12, 2021 /PRNewswire/ -- HistoSonics, (www.histosonics.com), the developer and manufacturer of a non-invasive platform and novel sonic beam therapy called histotripsy, is pleased to announce that the...
MINNEAPOLIS, July 12,...
07/12/2021
IO Learning

Advertisement

News
Miami Cancer Institute Enrolls First Patients in Single-Fraction Stereotactic MRI-Guided Adaptive Radiation Therapy for Inoperable Primary or Metastatic Cancer Trial
07/07/2021
Investigator-Led Study Explores Feasibility and Tolerability of Single-fraction Stereotactic Ablative Body Radiotherapy Using MRIdian's Daily MRI-Guidance with On-Table Adaptive Replanning
Investigator-Led Study Explores Feasibility and Tolerability of Single-fraction Stereotactic Ablative Body Radiotherapy Using MRIdian's Daily MRI-Guidance with On-Table Adaptive Replanning
Investigator-Led Study Explores...
07/07/2021
IO Learning
News
First Photon Treatment Using Raystation in India by Mahatma Gandhi Cancer Hospital
06/29/2021
STOCKHOLM, June 29, 2021 /PRNewswire/ -- RaySearch Laboratories AB (publ) announces that RayStation®* now is in clinical use at Mahatma Gandhi Cancer Hospital & Research Institute (MGCH & RI), in...
STOCKHOLM, June 29, 2021 /PRNewswire/ -- RaySearch Laboratories AB (publ) announces that RayStation®* now is in clinical use at Mahatma Gandhi Cancer Hospital & Research Institute (MGCH & RI), in...
STOCKHOLM, June 29,...
06/29/2021
IO Learning

Subscribe

IO Learning Newsletter

News

News
Novel Endovascular Robotic Surgical System Reaches Midpoint of Pivotal Clinical Trial
09/20/2024
The ACCESS-PVI trial of LIBERTY® Endovascular Robotic Surgical System has enrolled and completed follow-up for 50% of patients.
The ACCESS-PVI trial of LIBERTY® Endovascular Robotic Surgical System has enrolled and completed follow-up for 50% of patients.
The ACCESS-PVI trial of LIBERTY®...
09/20/2024
IO Learning
News
Histotripsy Demonstrates Technical Success, Safety for Primary and Metastatic Liver Tumors
09/04/2024
According to results from the parallel #HOPE4LIVER trials, the novel ablation technique of histotripsy met coprimary end points for technical success and safety among patients with primary and metastatic liver tumors.
According to results from the parallel #HOPE4LIVER trials, the novel ablation technique of histotripsy met coprimary end points for technical success and safety among patients with primary and metastatic liver tumors.
According to results from the...
09/04/2024
IO Learning
News
Sorafenib Plus Transarterial Chemoembolization Improves Survival Outcomes, Response Among Patients With Recurrent Hepatocellular Carcinoma
07/29/2024
According to a phase 3 trial, the addition of sorafenib to TACE improved survival outcomes and response among patients with recurrent intermediate-stage hepatocellular carcinoma after R0 initial hepatectomy and microvascular invasion.
According to a phase 3 trial, the addition of sorafenib to TACE improved survival outcomes and response among patients with recurrent intermediate-stage hepatocellular carcinoma after R0 initial hepatectomy and microvascular invasion.
According to a phase 3 trial,...
07/29/2024
Oncology
News
Thermal Ablation Over Surgical Resection for Patients With Smaller Colorectal Liver Metastases
07/18/2024
According to the phase 3 COLLISION trial, thermal ablation for smaller colorectal liver metastases reduced morbidity and mortality without compromising survival outcomes compared to surgical resection.
According to the phase 3 COLLISION trial, thermal ablation for smaller colorectal liver metastases reduced morbidity and mortality without compromising survival outcomes compared to surgical resection.
According to the phase 3...
07/18/2024
IO Learning
News
Manageable Safety Across Treatment Periods for Durvalumab, Bevacizumab, and TACE Regimen Among Patients With Unresectable Hepatocellular Carcinoma
07/17/2024
According to a post-hoc, exploratory analysis of safety by treatment period in the EMERALD-1 study, durvalumab plus bevacizumab plus transarterial chemoembolization had a manageable safety profile across both treatment periods among patients...
According to a post-hoc, exploratory analysis of safety by treatment period in the EMERALD-1 study, durvalumab plus bevacizumab plus transarterial chemoembolization had a manageable safety profile across both treatment periods among patients...
According to a post-hoc,...
07/17/2024
IO Learning
News
Transit Scientific Announces First Worldwide Case Performed with Innovative Embolic-Delivery Microcatheter
07/09/2024
Transit Scientific Press Release Park City, Utah USA, July 9, 2024 – Transit Scientific, a Utah-based medical device company specializing in innovative solutions for vascular procedures, proudly announces the successful debut of XO...
Transit Scientific Press Release Park City, Utah USA, July 9, 2024 – Transit Scientific, a Utah-based medical device company specializing in innovative solutions for vascular procedures, proudly announces the successful debut of XO...
Transit Scientific Press...
07/09/2024
Vascular Disease Management
Imaging Systems
University Hospitals Cleveland, Siemens Healthineers in New Alliance to Improve Oncology, Cardiovascular and Neurovascular Care for Patients
05/08/2024

Siemens Healthineers and University Hospitals Cleveland News

Siemens Healthineers and University H...
The new alliance will enhance cardiovascular services of the UH Harrington Heart & Vascular Institute with the world’s first clinically available photon-counting CT scanner and the new dual-source CT scanner.
The new alliance will enhance cardiovascular services of the UH Harrington Heart & Vascular Institute with the world’s first clinically available photon-counting CT scanner and the new dual-source CT scanner.
The new alliance will enhance...
05/08/2024
Cath Lab Digest
News
Histotripsy Treatment for Primary and Metastatic Liver Tumors
04/25/2024
At the 2023 CIRSE Annual Meeting, first results from the #HOPE4LIVER trial evaluating histotripsy for primary and metastatic liver tumors were reported.
At the 2023 CIRSE Annual Meeting, first results from the #HOPE4LIVER trial evaluating histotripsy for primary and metastatic liver tumors were reported.
At the 2023 CIRSE Annual...
04/25/2024
IO Learning
News
First-of-Its-Kind Surgical Foam Technology Improves Operating Room Workflow
04/24/2024

Syntervention Press Release

Syntervention Press Release
Rocky Mount, North Carolina, USA, April 24, 2024 — Syntervention, Inc., a medical device company focused on meeting critical needs in the healthcare space, announces the impact of using its SWICKER® Radiopaque Surgical Foam Sponge in open...
Rocky Mount, North Carolina, USA, April 24, 2024 — Syntervention, Inc., a medical device company focused on meeting critical needs in the healthcare space, announces the impact of using its SWICKER® Radiopaque Surgical Foam Sponge in open...
Rocky Mount, North Carolina,...
04/24/2024
EP Lab Digest
News
Fluidx Medical Reveals New Embolic Platform for Internal Bleeding, Tumor Treatment, and Other Uses
11/30/2023
Salt Lake City (UT) – Fluidx Medical today released information about their new ULTRA™ embolic platform designed to make therapeutic embolization procedures safer, better, and faster.   Embolization is a minimally invasive...
Salt Lake City (UT) – Fluidx Medical today released information about their new ULTRA™ embolic platform designed to make therapeutic embolization procedures safer, better, and faster.   Embolization is a minimally invasive...
Salt Lake City (UT) – Fluidx...
11/30/2023
Vascular Disease Management

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use